Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Oaktree Acquisition (OAC) Competitors

OAC vs. OPCH, BTSG, PTCT, ALKS, HNGE, SHC, PCVX, ACAD, KRYS, and ACLX

Should you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Option Care Health (OPCH), BrightSpring Health Services (BTSG), PTC Therapeutics (PTCT), Alkermes (ALKS), Hinge Health (HNGE), Sotera Health (SHC), Vaxcyte (PCVX), ACADIA Pharmaceuticals (ACAD), Krystal Biotech (KRYS), and Arcellx (ACLX). These companies are all part of the "medical" sector.

Oaktree Acquisition vs. Its Competitors

Oaktree Acquisition (NYSE:OAC) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Option Care Health has higher revenue and earnings than Oaktree Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree AcquisitionN/AN/A$1.15MN/AN/A
Option Care Health$5.37B0.86$211.82M$1.2522.78

Option Care Health has a consensus target price of $35.75, suggesting a potential upside of 25.53%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than Oaktree Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Option Care Health
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

In the previous week, Option Care Health had 17 more articles in the media than Oaktree Acquisition. MarketBeat recorded 17 mentions for Option Care Health and 0 mentions for Oaktree Acquisition. Option Care Health's average media sentiment score of 1.78 beat Oaktree Acquisition's score of 0.00 indicating that Option Care Health is being referred to more favorably in the news media.

Company Overall Sentiment
Oaktree Acquisition Neutral
Option Care Health Very Positive

47.6% of Oaktree Acquisition shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Oaktree Acquisition has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

Option Care Health has a net margin of 3.93% compared to Oaktree Acquisition's net margin of 0.00%. Option Care Health's return on equity of 17.53% beat Oaktree Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree AcquisitionN/A N/A N/A
Option Care Health 3.93%17.53%7.17%

Summary

Option Care Health beats Oaktree Acquisition on 13 of the 13 factors compared between the two stocks.

Get Oaktree Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OAC vs. The Competition

MetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE Exchange
Market Cap$1.40B$33.61M$5.84B$21.58B
Dividend YieldN/AN/A5.68%3.49%
P/E RatioN/AN/A75.4129.75
Price / SalesN/A0.60515.8186.27
Price / Cash377.4554.0337.5625.00
Price / Book277.500.3912.154.58
Net Income$1.15M-$7.06M$3.29B$999.94M

Oaktree Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OAC
Oaktree Acquisition
N/A$55.50
+7.2%
N/A+234.9%$1.40BN/A0.00N/AHigh Trading Volume
OPCH
Option Care Health
4.8738 of 5 stars
$28.70
-1.9%
$35.75
+24.6%
-11.0%$4.75B$5.00B22.968,088News Coverage
Positive News
BTSG
BrightSpring Health Services
2.4623 of 5 stars
$28.08
+7.0%
$27.10
-3.5%
+91.0%$4.65B$11.27B90.5835,000News Coverage
Analyst Forecast
High Trading Volume
PTCT
PTC Therapeutics
3.6637 of 5 stars
$58.33
-0.2%
$69.00
+18.3%
+79.7%$4.64B$806.78M8.371,410News Coverage
Positive News
Insider Trade
ALKS
Alkermes
4.5512 of 5 stars
$26.93
-3.3%
$42.00
+56.0%
-2.5%$4.60B$1.56B12.951,800Trending News
Analyst Forecast
HNGE
Hinge Health
N/A$56.05
-2.2%
$55.73
-0.6%
N/A$4.50BN/A0.001,514News Coverage
Analyst Forecast
SHC
Sotera Health
2.1758 of 5 stars
$15.74
-0.4%
$16.00
+1.7%
-4.5%$4.49B$1.10B196.773,000Insider Trade
PCVX
Vaxcyte
2.3473 of 5 stars
$32.00
-2.2%
$121.75
+280.5%
-72.3%$4.25BN/A-7.79160News Coverage
Positive News
Analyst Forecast
ACAD
ACADIA Pharmaceuticals
4.3773 of 5 stars
$23.80
-4.2%
$29.06
+22.1%
+44.7%$4.19B$957.80M17.89510News Coverage
Analyst Forecast
KRYS
Krystal Biotech
4.924 of 5 stars
$137.46
-2.7%
$210.38
+53.0%
-28.7%$4.09B$290.52M27.94210Positive News
ACLX
Arcellx
2.2838 of 5 stars
$72.71
+0.9%
$114.31
+57.2%
-0.9%$4.00B$107.94M-21.2680News Coverage
Positive News

Related Companies and Tools


This page (NYSE:OAC) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners